Literature DB >> 26629987

Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) in Aging Populations.

Carlos A Vaz Fragoso1,2.   

Abstract

Current epidemiologic practice evaluates COPD based on self-reported symptoms of chronic bronchitis, self-reported physician-diagnosed COPD, spirometry confirmed airflow obstruction, or emphysema diagnosed by volumetric computed chest tomography (CT). Because the highest risk population for having COPD includes a predominance of middle-aged or older persons, aging related changes must also be considered, including: 1) increased multimorbidity, polypharmacy, and severe deconditioning, as these identify mechanisms that underlie respiratory symptoms and can impart a complex differential diagnosis; 2) increased airflow limitation, as this impacts the interpretation of spirometry confirmed airflow obstruction; and 3) "senile" emphysema, as this impacts the specificity of CT-diagnosed emphysema. Accordingly, in an era of rapidly aging populations worldwide, the use of epidemiologic criteria that do not rigorously consider aging related changes will result in increased misidentification of COPD and may, in turn, misinform public health policy and patient care.

Entities:  

Keywords:  COPD; GOLD; aging; epidemiology; spirometry

Mesh:

Year:  2015        PMID: 26629987      PMCID: PMC6094385          DOI: 10.3109/15412555.2015.1077506

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  41 in total

Review 1.  Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program.

Authors:  G T Ferguson; P L Enright; A S Buist; M W Higgins
Journal:  Chest       Date:  2000-04       Impact factor: 9.410

2.  Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%.

Authors:  James E Hansen; Xing-Guo Sun; Karlman Wasserman
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

3.  Respiratory symptoms, spirometric respiratory impairment, and respiratory disease in middle-aged and older persons.

Authors:  Brian S Marcus; Gail McAvay; Thomas M Gill; Carlos A Vaz Fragoso
Journal:  J Am Geriatr Soc       Date:  2015-01-30       Impact factor: 5.562

4.  Phenotype of normal spirometry in an aging population.

Authors:  Carlos A Vaz Fragoso; Gail McAvay; Peter H Van Ness; Richard Casaburi; Robert L Jensen; Neil MacIntyre; Thomas M Gill; H Klar Yaggi; John Concato
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 21.405

5.  Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitions.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; Peter H Van Ness; Carolyn L Rochester; H Klar Yaggi; Thomas M Gill
Journal:  Respir Med       Date:  2010-03-03       Impact factor: 3.415

6.  Lower Extremity Proximal Muscle Function and Dyspnea in Older Persons.

Authors:  Carlos A Vaz Fragoso; Katy Araujo; Linda Leo-Summers; Peter H Van Ness
Journal:  J Am Geriatr Soc       Date:  2015-07-22       Impact factor: 5.562

7.  The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation.

Authors:  R Peto; F E Speizer; A L Cochrane; F Moore; C M Fletcher; C M Tinker; I T Higgins; R G Gray; S M Richards; J Gilliland; B Norman-Smith
Journal:  Am Rev Respir Dis       Date:  1983-09

8.  Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.

Authors:  Andrea Gershon; Ruth Croxford; Andrew Calzavara; Teresa To; Matthew B Stanbrook; Ross Upshur; Thérèse A Stukel
Journal:  JAMA Intern Med       Date:  2013-07-08       Impact factor: 21.873

9.  Ethnic differences in respiratory impairment.

Authors:  Carlos A Vaz Fragoso; Gail McAvay; Thomas M Gill; John Concato; Philip H Quanjer; Peter H Van Ness
Journal:  Thorax       Date:  2013-08-12       Impact factor: 9.139

10.  Respiratory impairment in older persons: when less means more.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Gail McAvay; Philip H Quanjer; Peter H Van Ness; John Concato
Journal:  Am J Med       Date:  2012-11-20       Impact factor: 4.965

View more
  10 in total

Review 1.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

2.  Erythromycin attenuates metalloprotease/anti-metalloprotease imbalance in cigarette smoke-induced emphysema in rats via the mitogen-activated protein kinase/nuclear factor-κB activation pathway.

Authors:  Xiaoming Zhou; Dongxue Gu; Gang Hou
Journal:  Mol Med Rep       Date:  2017-03-30       Impact factor: 2.952

3.  Relative and absolute lung function change in a general population aged 60-102 years.

Authors:  Johannes Luoto; Mats Pihlsgård; Per Wollmer; Sölve Elmståhl
Journal:  Eur Respir J       Date:  2019-03-14       Impact factor: 16.671

Review 4.  Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments.

Authors:  Li Zuo; Evan R Prather; Mykola Stetskiv; Davis E Garrison; James R Meade; Timotheus I Peace; Tingyang Zhou
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

5.  Bronchoscopic lung volume reduction procedures for emphysema: A network meta-analysis.

Authors:  Wu Xu; Junyi Wang; Xiang He; Junlan Wang; Dehong Wu; Guoping Li
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

6.  Variable DNA methylation of aging-related genes is associated with male COPD.

Authors:  Xizi Du; Lin Yuan; Mengping Wu; Meichao Men; Ruoxi He; Leyuan Wang; Shuangyan Wu; Yang Xiang; Xiangping Qu; Huijun Liu; Xiaoqun Qin; Chengping Hu; Ling Qin; Chi Liu
Journal:  Respir Res       Date:  2019-11-04

Review 7.  Combined Antioxidant, Anti-inflammaging and Mesenchymal Stem Cell Treatment: A Possible Therapeutic Direction in Elderly Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Shijin Xia; Changxi Zhou; Bill Kalionis; Xiaoping Shuang; Haiyan Ge; Wen Gao
Journal:  Aging Dis       Date:  2020-02-01       Impact factor: 6.745

8.  The DNA methylation of FOXO3 and TP53 as a blood biomarker of late-onset asthma.

Authors:  Lin Yuan; Leyuan Wang; Xizi Du; Ling Qin; Ming Yang; Kai Zhou; Mengping Wu; Yu Yang; Zhiyuan Zheng; Yang Xiang; Xiangping Qu; Huijun Liu; Xiaoqun Qin; Chi Liu
Journal:  J Transl Med       Date:  2020-12-09       Impact factor: 5.531

9.  Secular Trends of Mortality and Years of Life Lost Due to Chronic Obstructive Pulmonary Disease in Wuhan, China from 2010 to 2019: Age-Period-Cohort Analysis.

Authors:  Yan Guo; Jianjun Bai; Xiaoxia Zhang; Qiman Jin; Yijun Liu; Chuanhua Yu
Journal:  Int J Environ Res Public Health       Date:  2022-08-27       Impact factor: 4.614

Review 10.  Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease.

Authors:  Molly Easter; Seth Bollenbecker; Jarrod W Barnes; Stefanie Krick
Journal:  Int J Mol Sci       Date:  2020-09-21       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.